4th German Pharm-Tox Summit

      Date
      Feb 25, 2019 - Feb 28, 2019
      Location
      Stuttgart, Germany

      The 4th German Pharm-Tox Summit will take place from 25–28 February 2019 in Stuttgart. Traditionally, this is a joint conference organised and held by the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT) together with the Association of Clinical Pharmacology (VKliPha) and the Association for Applied Human Pharmacology (AGAH). To make the 4th German Pharm-Tox Summit an excellent scientific congress presenting cutting edge science from experimental and clinical Pharmacology and Toxicology, for the first time two Universities, namely Tübingen and Ulm, also represented by the two Congress Presidents from the German Societies of Clinical Pharmacology and Toxicology, respectively, join together with the Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology in Stuttgart. The three plenary talks as well as the various symposia and the short talks sessions will provide exciting insight on hot topics of pharmacology, clinical pharmacology, and toxicology, but also allow to look across the borders of the own research topics.

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.